Renal fibrosis

Hippokratia

Volumn 13, Issue 4, 2009, Pages 224-228

  Efstratiadis, Georgios ^a,b   Divani, M ^a   Katsioulis, E ^a   Vergoulas, G ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b AHEPA Hospital ^*  (Greece)

Author keywords

Angiotensin II; Cytokines; Epithelial mesenchymal transition; Fibrosis; Growth factors; Hypoxia; Proteinuria; TGF

Indexed keywords

HYPOXIA INDUCIBLE FACTOR; OSTEOGENIC PROTEIN 1; SCATTER FACTOR; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

CELL STIMULATION; EPITHELIUM CELL; FIBROSING ALVEOLITIS; HUMAN; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY INTERSTITIUM; KIDNEY PARENCHYMA; KIDNEY TUBULE; MESENCHYME CELL; PROTEINURIA; REVIEW;

EID: 70350155727     PISSN: 11084189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Kisselva T, Brenner DA. Fibrogenesis of parenphymal organs. Proc Am Thorac Soc. 2008; 5: 338-342.
2. Robertson H, Kirby JA, Yip WW, Jones DE, Burt AD. Biliary epithelial-mesenchymal transition in posttransplantation reccurence of primary biliary cirrhosis. Hepatology. 2007; 45: 977-981. (Pubitemid 46631566)
3. Willis BC, Boroc Z. TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease. Am J Physiol Lung Cell Mol Physiol. 2007; 293: L525-L534.
4. Liu Y. Epithelial to Mesenchymal Transition in Renal Fibrogenesis: Pathologic Significance, Molecular Mechanism, and Therapeutic Intervention. J Am Soc Nephrol. 2004; 15: 1-12. (Pubitemid 38020692)
5. Strutz F, O kada H, Lo C W, Danoff T, Carone RL, Tomaszewski JE, et al. Identification and characterization of a fibroblast marker: FSP1. J Cell Biol. 1995; 130: 393-405.
6. Rastaldi M P, Ferrario F, Giardino L, Dell' Antonio G, Grillo C, Grillo P, et al. Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies. Kidney Int. 2002; 62: 137-146. (Pubitemid 34754056)
7. Iwano M, Plieth D, Danoff T M, Xue C, Okada H, Neilson E G. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest. 2002; 110: 341-350. (Pubitemid 34847966)
8. Tsakas S, Goumenos DS. Accurate messurement and clinical significance of urinary transforming growth factor-beta. Am J Nephrol. 2006; 26: 186-193. (Pubitemid 43882404)
9. Goumenos DS, Tsakas S, El Nahas AM, Alexandri S, Oldroyd S, Kalliakmani P, et al. Transforming growth factor-beta1 in kidney and urine of patients with glomerular disease and proteinuria. Nephrol Dial Transplant. 2002; 17: 2145-2152. (Pubitemid 35446670)
10. Bagnasco S, Racusen L. Proteinuria and Epithilial-to-Mesenchymal Transition: The Role of Complement. J Am Soc Nephrol. 2009; 20: 459-460.
11. Abbate M, Zoja C, Remuzzi G. How does proteinuria cause progressive renal damage? J Am Soc Nephrol. 2006; 17: 2974-2984.
12. Ruggenenti P, Perna A, Remuzzi G, GISEN Group Inverstigators. Retarding progression of chronic renal disease: The neglected issue of residual proteinuria. Kidney Int. 2003; 63: 2254-2261. (Pubitemid 36605839)
13. Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol. 2008; 214: 199-210.
14. Tang Z, Bao L, Hatch E, Sacks SH, Sheerin NS. C3a mediates epithelial-to-mesenchymal transition in proteinuric nepropathy. J Am Soc Nephrol. 2009; 20: 593-603.
15. Ricardo SD, van Goor H, Eddy AA. Macrophage diversity in renal injury and repair. J Clin Invest. 2008; 118: 3522-3530.
16. Song JH, Cha SH, Lee HJ, Lee SW, Pask GH, Kim MJ. Effect of low-dose dual blockade of renin-angiotensin system on urinary TGF-β in type 2 diabetic patients with advanced kidney disease. Nephrol Dial Transplant. 2006; 21: 683-689.
17. Higgins D, Kimura K, Iwano M, Haase VH. Hypoxia-inducible factor signaling in the development of tissue fibrosis. Cell Cycle. 2008; 7: 1128-1132. (Pubitemid 351749261)
18. Higgins D, Kimura K, Bernhardt WM, Shrimarkes N, Akai V, Hohenstein B, et al. Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J Clin Invest. 2007; 117: 3810-3820. (Pubitemid 350224091)
19. Lucero HA, Kagan HM. Lysyl oxidase: an oxidative enzyme and effector of cell function. Cell Mol Life Sci. 2006; 63: 2304-2316.
20. Zhang H, Akman HO, Smith EL, Zhao J, Murphy - Ultrich JE, Batuman OA. Cellular response to Hypoxia involves signaling via Smad proteins. Blood. 2003; 101: 2253-2260.
21. Min-A Yu, Kyung-Sook Shin, Jung Hye Kim, Yu MA, Shin KS, Kim JH, et al. HGF and BMP-7 ameliorate high glucose- indused epithelial-to-mesenchymal transition of peritoneal mesothelium. J Am Soc Nephrol. 2009; 20: 567-581.
22. Zeisberg M. Bone morphogenic protein-7 and the kidney: Current concepts and open questions. Nephrol Dial Transplant. 2006; 21: 568-573. (Pubitemid 43372898)
23. Aroeira LS, Aguilera A, Sanchez-Tomero JA, del Peso G, Jimenes - Hefferman JA, Bajo MA, et al. Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: Pathologic significance and potential therapeutic interventions. J Am Soc Nephrol. 2007; 18: 2004-2013. (Pubitemid 47041064)
24. Matsuoka T, Maeda Y, Matsuo K, Naiki Y, Tamai Y, Sakaguchi M, et al. Hepatocyte growth factor prevents peritoneal fibrosis in an animal model of encapsulating peritoneal sclerosis. J Nephrol. 2008; 21: 64-73. (Pubitemid 351780575)
25. Yang J, Dai C, Liu Y. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition. J Am Soc Nephrol. 2005; 16: 68-78. (Pubitemid 43073158)